| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(86)90497-3 |
| P698 | PubMed publication ID | 3524215 |
| P2093 | author name string | McCracken GH Jr | |
| P2860 | cites work | Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 | Q24671879 |
| P433 | issue | 6B | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 172-178 | |
| P577 | publication date | 1986-06-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Aminoglycoside toxicity in infants and children | |
| P478 | volume | 80 |
| Q44145529 | A pilot case control follow-up study on hearing in children treated with tobramycin in the newborn period |
| Q36749859 | Amikacin-induced Fin Reduction is Mediated by Autophagy |
| Q39634450 | Aminoglycoside antibiotics in clinical use. |
| Q38181171 | Aminoglycoside toxicity in neonates: something to worry about? |
| Q38676819 | Aminoglycoside-induced hearing loss in humans |
| Q36955843 | Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis |
| Q24244652 | Antibiotics for neonates born through meconium stained amniotic fluid |
| Q38704401 | Antibiotics for neonates born through meconium-stained amniotic fluid. |
| Q94397763 | Antibiotics for the management of [suspected] transient tachypnea of the newborn |
| Q94338434 | Antibiotics for the management of transient tachypnea of the newborn |
| Q33736248 | Antibiotics in neonatal infections: a review. |
| Q50434466 | Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit |
| Q50555523 | Auditory function after continuous infusion of gentamicin to high-risk newborns. |
| Q40561487 | Bayesian pharmacokinetic analysis of a gentamicin nomogram in neonates: a retrospective study |
| Q38043978 | Caring for children with drug-resistant tuberculosis: practice-based recommendations. |
| Q36120465 | Clinical Pharmacology Studies in Critically Ill Children. |
| Q37956835 | Clinical pharmacokinetics of antibacterial drugs in neonates |
| Q33788040 | Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin |
| Q40593840 | Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies. |
| Q36322918 | Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children |
| Q46094288 | Enzymuria determination in children treated with aminoglycosides drugs. |
| Q68503958 | Evaluation of an Empirical Dosing Schedule for Gentamicin in Neonates |
| Q40594113 | Experimental, clinical and preventive aspects of ototoxicity |
| Q34844964 | Gentamicin as gene therapy |
| Q73549374 | Isepamicin versus amikacin for the treatment of acute pyelonephritis in children |
| Q28540814 | Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial. |
| Q42544915 | Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity |
| Q37703550 | Mentha piperita in nephrotoxicity--a possible intervention to ameliorate renal derangements associated with gentamicin |
| Q39611425 | Nephrotoxic drugs |
| Q50498817 | Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children. |
| Q70478097 | Pediatric critical care pharmacodynamics |
| Q37621548 | Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates |
| Q35066606 | Pharmacokinetics and antibacterial activity of daily gentamicin |
| Q77050522 | Pharmacokinetics of once-daily gentamicin dosing in pediatric patients |
| Q30488140 | Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics |
| Q67485166 | The Use of Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis to Detect Renal Damage in Sprague-Dawley Rats Treated with Gentamicin Sulfate |
| Q35579098 | The effect of radiotherapy on gentamicin ototoxicity: an animal model |
| Q44380929 | The need for long-term audiologic follow-up of neonatal intensive care unit (NICU) graduates |
| Q35653978 | Time course of trough serum gentamicin concentrations in preterm and term neonates |
| Q42666715 | Tobramycin population pharmacokinetics in neonates. |
| Q35329151 | Treatment options for the pharmacological therapy of neonatal meningitis |
| Q36446895 | Understanding drug ototoxicity: molecular insights for prevention and clinical management |
| Q28276776 | Validation of a simplified netilmicin dosage regimen in infants |
| Q34180493 | What is the right dose for children? |
| Q36446781 | d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models |
Search more.